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Conclusion: Despite advances in antiretroviral therapy, which
has signiﬁcantly improved virological suppression, HAND continues to remain a signiﬁcant complication among PLHIV.
https://doi.org/10.1016/j.ijid.2020.09.764
0702
Retention and predictors of attrition among
children living with HIV on antiretroviral
therapy (ART) in Côte d’Ivoire between 2012 and
2016
F. Traore-Toure 1 , G. Etheredge 2 , G. Shah 3,∗ , C.
Brennan 4
1 formerly FHI 360, ISPEC Project, Cote d’Ivoire,
Abidjan/CI, United States
2 FHI 360, Infectious Diseases & Health Systems,
Global Health, Population & Nutrition, Washington,
DC, United States
3 Georgia Southern University, Jiann-Ping Hsu
College of Public Health, Health Policy and
Community Health, Statesboro, GA, United States
4 FHI 360, Health Services Research, Global Health,
Population & Nutrition, Durham, NC, United States

Background: In Côte d’Ivoire a retrospective national-level
cohort study conducted in 2009 indicated that 77%, 72% and 75%
of children living with HIV (CLHIV) remained in care at 12, 36,
and 48 months after starting ART, respectively. The CDC-sponsored
Improving HIV Surveillance and Program Evaluation in Côte d’Ivoire
project assessed retention progress since that study.
Methods and materials: A retrospective review of medical
records was conducted using 2-stage cluster sampling. HIV care and
treatment centers (CTC) were sampled based on patient caseload,
then records of patients under 15 years of age who initiated ART
between 2012–2016 were randomly selected. Time-to-event analysis was performed to estimate the cumulative attrition rates per
total number of person-years (PYs) of observation. Cox proportional
hazard regressions were conducted to identify factors associated
with attrition.
Results: 1198 patient records from 33 CTC were reviewed.
At time of ART initiation, CLHIVs’ mean age was 5.8 years, 609
(51%) were male, median CD4 count was 529 cells/L (interquartile range: 270-910), and 210 (21%) were severely undernourished.
Retention was 91%, 84%, 74%, 72%, and 70% at 12, 24, 36, 48 and
60 months after ART initiation, respectively. 309 attrition events
occurred over 3,169 PYs of follow-up, with 266 lost to follow-up
(LTFU), 29 transfers and 14 deaths. Multivariate analyses showed
determinants for LTFU included attending a CTC with a mixed
(public-private) status [adjusted hazard ratio (aHR) 6.05, 95% conﬁdence interval (CI): 4.23–8.65], a CTC with no on-site laboratory
(aHR 4.01, 95% CI: 1.70–9.46), and a CTC without an electronic
medical record system (aHR 2.22, 95% CI: 1.59–3.12). Age, clinical
and immunological status at ART initiation, and parent’s HIV status
were not related to attrition.
Conclusion: Attrition rates were high, with no substantial
improvement since 2009 for time periods longer than 12 months
since ART initiation. Retention improvements in Cote d’Ivoire
would require a focus on scaling up innovative service delivery
models such as decentralization of services to the community, coordination with local or regional labs for facilities without an on-site
laboratory, and rigorous tracking systems for patients in care.
https://doi.org/10.1016/j.ijid.2020.09.765
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Background: To provide efﬁcient, equitable, patient-centered,
and evidence-based services to people living with HIV/AIDS
(PLWH), it is critical for the intervention programs to understand
the nature of barriers to effective treatment and additional risks
faced by PLWH with tuberculosis (TB) coinfection. This study analyzes two aspects of TB coinfection in PLWH: (a) variation in TB/HIV
coinfection by demographic and clinical characteristics of patients;
and (b) risks of negative outcomes such as death, loss to follow up,
and higher viral load among PLWH with TB coinfection compared
to those without such coinfection.
Methods and materials: This quantitative study used data on
49,460 PLWH on ART from 241 HIV/AIDS clinics in two provinces
of Democratic Republic of Congo, Haut-Katanga and Kinshasa. Chisquare and logistic regression analyses were performed. Three
separate logistic regression analyses were performed to estimate
the impact of TB status on three dichotomous dependent variables:
death, LTFU (vs. in care or transferred out), and viral load above
1,000 copies per ml of blood, after controlling for other variables.
Results: Signiﬁcantly higher proportions of patients with
TB/HIV coinfection were males (4.5% vs. 3.3%); new patients rather
than transferred-in (3.7% vs. 1.6%) resided in the Kinshasa province
rather than Haut-Katanga (4.0% vs. 2.7%) and were in an urban
health zone (3.9%) and semi-rural (3.1%) rather than rural (1.2%)
health zone. The logistic regression models showed that after
controlling for other demographic and clinical variables, TB/HIV
coinfection raised the risk of death (AOR, 2.26; CI, 1.94–2.64) and
loss to follow up (AOR, 2.06; CI, 1.82 to B/HIV coinfection lowered
the odds of viral load suppression (VLS) below 1,000 copies per ml
of blood (AOR, 0.58; CI, 0.46–0.74).
Conclusion: TB/HIV coinfection raises the risk of negative outcomes such as death, loss to follow up, and inability to have viral
load suppressed below 1,000 copies per ml. HIV clinics in DRC
and other African countries may consider these ﬁndings when
customizing their interventions to improve HIV care and reduce
disparities in PLWH.
https://doi.org/10.1016/j.ijid.2020.09.767

